Phase 3 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with colorectal cancer (bowel cancer) that has spread to the liver, confirmed by a tissue sample (biopsy)
- You have at least one liver tumour that can be measured using standard scanning methods
- Your cancer has only spread to the liver, or if it has also spread to the lungs, there are no more than 3 lung spots and each one is smaller than 10mm
- Your tumour has been tested to find out whether it has specific gene changes (called RAS, KRAS, and NRAS mutations)
- You are 18 years old or older
- You are reasonably well and able to carry out daily activities (confirm with trial site regarding exact fitness level required)
- You have not had chemotherapy before, unless it was given around the time of surgery and finished more than 12 months ago
- Your doctors expect you to live for more than 3 months
- Your blood counts (white blood cells, platelets, and haemoglobin) are above certain minimum levels (confirm with trial site)
- Your liver and kidney function blood test results are within acceptable ranges (confirm with trial site)
- Your kidney function meets a minimum level measured by a specific calculation
- You are registered with a social security scheme (this appears to be a French healthcare requirement)
- You have been fully informed about the trial and have signed a consent form
Who may not be able to join:
- You have a blockage or unusual blood vessel structure in the liver artery that could affect a specific procedure or future surgery (confirm with trial site)
- Your doctors have already decided you are suitable for surgery or a procedure aimed at curing your cancer right now
- You have had a heart attack, chest pain, heart bypass surgery, significant heart failure, stroke, or mini-stroke in the past 6 months
- Your blood pressure is too high and cannot be controlled with medication
- You have had a hole or tear in your gut, an abscess in your abdomen, or significant gut bleeding in the past 6 months
- You currently have an active stomach or duodenal ulcer, an unhealed wound, or a broken bone that has not yet healed
- You have had major surgery or radiotherapy in the 4 weeks before starting the trial
- You have had an organ transplant, are HIV positive, or have another condition that affects your immune system
- You have had serious, ongoing liver, kidney, or breathing problems in the past 6 months that are not well controlled
- You have significant nerve damage in your hands or feet (peripheral neuropathy above a mild level)
- You have a lung condition called interstitial pneumonitis or pulmonary fibrosis
- You have a history of severe chronic diarrhoea, inflammatory bowel disease, or a current blockage in your bowel
- You have had another cancer in the past 5 years, unless it was a certain type of treated skin cancer or early-stage cervical cancer now in full remission
- You are already taking part in another clinical trial involving an experimental treatment
- You have a known allergy or serious reaction to any of the medicines used in this trial
- You have a known deficiency of an enzyme called DPD (which affects how certain chemotherapy drugs are processed by the body)
- Your heart's electrical activity (measured by an ECG) shows a reading that is too high (above 450 milliseconds for men or 470 milliseconds for women)
- Your blood levels of potassium, magnesium, or calcium are below the normal range
- You are pregnant, breastfeeding, or of childbearing age and not using effective contraception, or have not had a pregnancy test when required
- You are currently under legal supervision or have restrictions on your freedom
- It would not be possible for you to attend regular medical check-ups during the trial due to where you live, your personal situation, or other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julien TAIEB, MD-PhD, HEGP, Paris
Phone: +33 (0)380393404
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
progression-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.